To evaluate the impact of psychopharmacological medication intake on specific vitamin levels (e.g., A, D, B12) in patients after bariatric surgery.
Key Findings:
Psychopharmacological medication was documented in 132 of 524 patients (25%).
No significant differences in vitamin levels were found between patients taking psychopharmacological medication and those who were not, indicating that psychiatric treatment does not compromise vitamin status.
Vitamin deficiencies were assessed based on specific reference values for various vitamins.
Interpretation:
The presence of psychiatric disorders and the use of psychopharmacological medications did not adversely affect vitamin status in the long-term follow-up of bariatric surgery patients, highlighting the need for continued monitoring and support.
Limitations:
Retrospective design may introduce selection bias.
Potential confounding factors not fully controlled.
Adherence to supplementation was self-reported and may not accurately reflect actual intake.
Findings may not be generalizable to all bariatric surgery populations.
Conclusion:
Psychopharmacological medication does not influence vitamin status post-bariatric surgery, suggesting that adherence to vitamin supplementation may be maintained despite psychiatric treatment, which is crucial for patient health.
by Hannes Beiglböck, Alexander Kautzky, Paul Fellinger, Tamara Ranzenberger-Haider, Bianca Itariu, Thomas Wrba, Gerhard Prager, Alexandra Kautzky-Willer, Peter Wolf, Michael Krebs
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
